PCAF-primed EZH2 acetylation regulates its stability and promotes lung adenocarcinoma progression. - Wikidata - awgldk - TriplyDB

PCAF-primed EZH2 acetylation regulates its stability and promotes lung adenocarcinoma progression.

PCAF-primed EZH2 acetylation regulates its stability and promotes lung adenocarcinoma progression.

http://www.wikidata.org/entity/Q35476750

about

Histone hypoacetylation contributes to CXCL12 downregulation in colon cancer: impact on tumor growth and cell migration.PRC2 regulates RNA polymerase III transcribed non-translated RNA gene transcription through EZH2 and SUZ12 interaction with TFIIIC complex.Role of several histone lysine methyltransferases in tumor development.EZH2 is required for mouse oocyte meiotic maturation by interacting with and stabilizing spindle assembly checkpoint protein BubRI.PCAF-mediated acetylation of transcriptional factor HOXB9 suppresses lung adenocarcinoma progression by targeting oncogenic protein JMJD6.Epigenetic modifications promote the expression of the orphan nuclear receptor NR0B1 in human lung adenocarcinoma cells.Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer development PCAF acts as a gastric cancer suppressor through a novel PCAF-p16-CDK4 axis Effects of long noncoding RNA SPRY4-IT1-mediated EZH2 on the invasion and migration of lung adenocarcinoma.P/CAF mediates PAX3-FOXO1-dependent oncogenesis in alveolar rhabdomyosarcoma.Quantitative proteome-based systematic identification of SIRT7 substrates.CKII-SIRT1-SM22α loop evokes a self-limited inflammatory response in vascular smooth muscle cells.KATapulting toward Pluripotency and Cancer.The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer.Transgenerational programming of longevity through E(z)-mediated histone H3K27 trimethylation in Drosophila Kindlin-2 could influence breast nodule elasticity and improve lymph node metastasis in invasive breast cancer.Elevated expression of a pharmacologic Polycomb signature predicts poor prognosis in gastric and breast cancer.The Role of the Histone Methyltransferase Enhancer of Zeste Homolog 2 (EZH2) in the Pathobiological Mechanisms Underlying Inflammatory Bowel Disease (IBD).miR-17-5p down-regulation contributes to erlotinib resistance in non-small cell lung cancer cells.HOXB9 promotes endometrial cancer progression by targeting E2F3.

P2860

Q33888795-8B6FCFD1-DD81-4A0B-B2C9-BFDF7F653D77 Q35885921-F6AFA23A-1944-4989-9F78-49F75B0370DF Q36639797-BC1F0424-7573-4942-85EC-82E0CA741E6D Q37264331-BFB75B3B-D1BE-40F8-B82C-EC0B2173529A Q37507609-66078E08-2CE5-4374-BC8B-B9B537AD12A7 Q37536509-74C07D67-32CF-419B-B2B8-83A597580387 Q37545071-77568760-5509-431B-95F3-E09BD9E414A4 Q37545081-C2F53E03-29C1-4352-B6A3-E88F50D5AEB8 Q38695240-AD78406A-D485-4C8D-B472-E60DAB2D4094 Q38740103-0BEBCD9D-003F-4015-85BC-31C68805EFE6 Q38757374-D41DE6BC-6163-413F-A0CB-78CDDD4FA22D Q38832355-498B82C5-A91B-42F2-BFF9-F417DC538DAA Q38976614-A67981F9-AB24-4794-B1D4-602B0FCB872C Q39312009-AE0766A7-15AD-4801-9B85-65ADC7F3E28F Q40027583-87EC50F6-BA7B-44D9-8B57-8F4763940049 Q41845585-76BFFB47-6D40-43B6-A2B2-904158EDE405 Q42688119-C6F4606F-F91C-4C90-B21B-C7F2B5F82777 Q46382588-7FBE15D2-9F79-496B-9563-4C2D6552B420 Q51502591-8E4ACB39-8DBD-49BD-9C37-4C60ED259C53 Q55167079-38A84D5D-C217-47D4-B1FA-9485E7E2C113

P2860

PCAF-primed EZH2 acetylation regulates its stability and promotes lung adenocarcinoma progression.

http://www.wikidata.org/entity/Q35476750

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

PCAF-primed EZH2 acetylation r ...... ng adenocarcinoma progression.

@ast

PCAF-primed EZH2 acetylation r ...... ng adenocarcinoma progression.

@en

type

label

PCAF-primed EZH2 acetylation r ...... ng adenocarcinoma progression.

@ast

PCAF-primed EZH2 acetylation r ...... ng adenocarcinoma progression.

@en

prefLabel

PCAF-primed EZH2 acetylation r ...... ng adenocarcinoma progression.

@ast

PCAF-primed EZH2 acetylation r ...... ng adenocarcinoma progression.

@en

P1433

Q35476750-78AEE7ED-238F-4288-8827-49F1966CD0D4

P1476

Q35476750-2EF9AC3D-E9CC-46A2-BDCB-41B6C920462F

P2093

Q35476750-3EB60966-1201-4E5D-9EE0-2CEF6ADFF05D

Q35476750-495C25B4-7739-41CB-BFA8-3EA23C588A20

Q35476750-4E65000A-33E8-4764-9B8D-F5ABAC83947E

Q35476750-7BDDF189-06A4-4532-9DF6-7E51AA541DF9

Q35476750-AAD711BD-593E-459D-8DC9-02551A338C28

Q35476750-B315B22F-F829-48DA-8A15-B505E8D68925

Q35476750-D6778871-DFA2-44E8-BD10-37DC35BA2ED0

Q35476750-D7394BBB-60FB-41EB-8F28-8BC3CB427D49

Q35476750-FB66E30F-6926-4C6B-9645-08805D256EA7

Q35476750-FD822F50-53C2-4E21-A297-BEE59D308A41

P2860

Q35476750-0195C28A-28F1-45FF-8382-8B34CC89B083

Q35476750-0737DE93-D493-4A7A-846F-7022D460BE90

Q35476750-1782BFBA-D16A-4D9B-B770-9BF2C279A797

Q35476750-188EC099-B43A-42EB-B95F-11DF6AD385B5

Q35476750-1CBF9996-212D-48A5-AAB1-B780A3016DA8

Q35476750-2307711D-8E4B-4F7F-ADAB-D7AC1BF73777

Q35476750-23FFF544-2893-487A-AE7D-D9023EDF5B20

Q35476750-253EF14F-F093-4D3B-821A-55EF2EFFB517

Q35476750-2DC62BC1-B943-4F6A-8D3E-8C18F19CB012

Q35476750-31AA17C7-D29C-429F-93F1-FA6F5556CE24

P304

Q35476750-D1AD1876-38A4-4332-8206-579B8553BF47

P31

Q35476750-0A613863-6C12-4911-9997-F251CB405130

P356

Q35476750-9D44C043-C694-4049-B13B-C93BA985D637

P407

Q35476750-7B3E615F-254E-4B07-A8D4-74F038EE2F63

P433

Q35476750-66B40F49-5387-4ECF-8DFA-731301DBFC65

P478

Q35476750-61F55CFB-D40C-4A1D-A0BD-E15A5D19F7AA

P50

Q35476750-B1B6C398-FD80-410F-AF05-CF58003F5435

P577

Q35476750-3E456406-5585-41AC-A199-03FB3D021353

P5875

Q35476750-3A427521-5D65-46F7-ACF2-0D2168117A08

P698

Q35476750-C491B4BC-27A4-4200-8FAE-C24023D59AEC

P921

Q35476750-755C40C0-A181-460B-B94A-31825CB00E12

P932

Q35476750-B3629017-7EF3-4D3C-A528-A7FB28E09287

P356

P1433

Nucleic Acids Research

P1476

PCAF-primed EZH2 acetylation r ...... ung adenocarcinoma progression

@en

P2093

Chang Liu

http://www.w3.org/2001/XMLSchema#string

Hongquan Zhang

http://www.w3.org/2001/XMLSchema#string

Ji Ma

http://www.w3.org/2001/XMLSchema#string

Jun Zhan

http://www.w3.org/2001/XMLSchema#string

Junhu Wan

http://www.w3.org/2001/XMLSchema#string

Shuai Li

http://www.w3.org/2001/XMLSchema#string

Weigang Fang

http://www.w3.org/2001/XMLSchema#string

Xiaowei Xue

http://www.w3.org/2001/XMLSchema#string

Y Eugene Chin

http://www.w3.org/2001/XMLSchema#string

Yuping Xie

http://www.w3.org/2001/XMLSchema#string

P2860

hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase

Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation

Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2

Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase

O-GlcNAcylation regulates EZH2 protein stability and function

Lysine-5 acetylation negatively regulates lactate dehydrogenase A and is decreased in pancreatic cancer

Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation

Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA

Lysine acetylation: codified crosstalk with other posttranslational modifications

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

P304

3591-3604

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NAR/GKV238

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274086161

http://www.w3.org/2001/XMLSchema#string

P698

25800736

http://www.w3.org/2001/XMLSchema#string

P921

P932

4402543

http://www.w3.org/2001/XMLSchema#string